We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




European Commission Funds Development of Patient-Friendly Endoscopy System

By Biotechdaily staff writers
Posted on 09 Feb 2007
A group of nine European companies and universities have been awarded a multimillion-euro research contract to develop a patient-friendly, highly sensitive screening system for the detection of early cancer and pre-cancerous conditions in the gastrointestinal tract. More...
The Nano-based capsule-Endoscopy with Molecular Imaging and Optical biopsy (NEMO) project will be funded under the auspices of the European Commission of the Sixth EU Framework Program of Research and Technological Development (FP6 commission).

The NEMO project is based on the Given Imaging (Yoqneam, Israel) PillCam video capsule. This device comprises a disposable, miniature video camera contained in a capsule, which is ingested by the patient, a sensor array, data recorder, and dedicated software.

Several of the research partners are engineering firms whose task will be to upgrade and enhance the electronic and mechanical systems built into the capsule. Another aspect of the project is the insertion or attachment of an immunodiagnostic test to the capsule that will allow real-time diagnosis of lesions spotted by capsule video. Novamed Ltd. (Jerusalem, Israel) is leading this section of the project in cooperation with hospitals and clinical laboratories in Germany and Italy.

We are proud to advance our research in the bio-sensing field with such leading research and industrial organizations,” said Dr. Elisha Rabinovitz, chief scientist of Given Imaging. "This project further exemplifies Given's commitment to develop new and innovative solutions to help physicians treat their patients and could represent a revolutionary platform of biopsy-free procedures.”




Related Links:
Given Imaging
Novamed Ltd.

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Slide Scanner System
NanoZoomer S540MD
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

UK Project Advances Blood-Based Dementia Testing Toward Routine Clinical Care

Dementia is the leading cause of death in the UK, accounting for almost one in eight deaths, with more than 72,000 people dying from dementia, including Alzheimer’s disease, in 2025. Despite this burden,... Read more

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.